IOLCP Submits Newspaper Publication on Special Window for Share Transfer
IOL Chemicals and Pharmaceuticals Limited has published notices regarding a special window for the transfer and dematerialisation of physical shares. This window is open from February 5, 2026, to February 4, 2027, to facilitate the process for eligible shareholders.
This is a procedural announcement related to share transfers and dematerialisation, which is a standard regulatory requirement and does not have a direct or significant impact on the company's operations or financial performance.
The announcement is a routine regulatory filing regarding a special window for share transfer and dematerialisation, with no immediate financial or operational impact that would sway sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has submitted copies of newspaper publications regarding a Special Window for Transfer-cum-Dematerialisation of Physical Shares. The publications were made on 18th August 2026 in the Financial Express (English) and Punjabi Jagran (Punjabi).
This announcement is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Special Window, which commenced on 5th February 2026 and will close on 4th February 2027, facilitates the transfer and dematerialisation of physical shares. This facility is applicable for shares where the original transfer deed was executed before 15th April 2019 and the transfer request was lodged prior to 1st April 2018 but returned, rejected, or remained unattended due to documentation deficiencies, or where the transfer request was not lodged prior to 1st April 2018 and the shareholder continues to hold the original share certificate with a duly executed transfer deed.
Shares transferred during this window will be processed only in dematerialized form and will remain under lock-in for one year from the date of registration of transfer. Shareholders are requested to submit their re-lodgment requests along with all requisite documents to the Company's Registrar and Share Transfer Agent, Alankit Assignments Limited.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.